Media News

PHILADELPHIA, Nov. 3, 2021 /PRNewswire/ -- ERT, the global clinical endpoint technology leader, today announced that following its early Q2 merger with Bioclinica, a technological and scientific leader in medical imaging, the combined company is renamed Clario. Clario is a technology company that generates the richest clinical evidence by fusing scientific expertise and...

SEOUL, South Korea, Nov. 3, 2021 /PRNewswire/ -- Standigm Inc. ("Standigm"), the leading workflow artificial intelligence (AI) drug discovery company, announced today that the company had filed PCT ("Patent Cooperation Treaty") patent application covering AI-driven repurposed drugs for primary mitochondrial disease through successful research collaboration with a US hospital, which has world-renowned...

SHANGHAI and GAITHERSBURG, Md., Nov. 3, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced its participation in the following conferences in November. Details of the conferences and management presentation are as follows: Goldman Sachs Asia Pacific Healthcare Forum...

SHENZHEN, China, Nov. 3, 2021 /PRNewswire/ -- As reported by Indonesian National Agency of Drug and Food Control (BPOM), BPOM grants the Emergency Use Authorization (EUA) for COVID-19 Vaccine (ChAdOx1-S)/KconecaVac manufactured by Shenzhen Kangtai Biological Products Co., Ltd. It is understood that this is China's second adenovirus vector COVID-19 vaccine approved for emergency use overseas. BPOM source:...

HONG KONG, Nov. 3, 2021 /PRNewswire/ -- Zenyum, a 2021 LinkedIn Top Startup that is disrupting cosmetic dentistry, is partnering with INSEAD, The Business School for the World, to sponsor partner dentists based in six of Zenyum's fast-growing markets. Dentists across Singapore, Hong Kong, Taiwan, Malaysia, Vietnam, and Thailand will enrol in a two-month professional development program, which aims...

DÜSSELDORF, Germany, Nov. 3, 2021 /PRNewswire/ -- Chinese biotechnology company Nanjing Vazyme Biotech Co., Ltd (Vazyme) will exhibit its advanced COVID-19 testing products and solutions in Hall 3 Stand F 94 at MEDICA 2021, the world's leading trade fair for the medical sector, in Messe Düsseldorf (Germany) from November 15 to November 18. The event provides visitors with a broad...

LONDON, Nov. 3, 2021 /PRNewswire/ -- In his recent opening address to the G20, Italian Prime Minister Mario Draghi highlighted vaccine inequity, emphasizing the fact that only 3% of eligible people living in the world's poorest nations had received any form of COVID-19 vaccine, versus more than 70% in high-income countries. Mr. Draghi stated, "These differences are morally unacceptable and...

SINGAPORE, Nov. 3, 2021 /PRNewswire/ -- As a result of the pandemic, boosting one's immune system has never been more crucial. Consisting of numerous chemicals, cells, proteins, and tissues that work together, the immune system is responsible for creating, storing, and distributing white blood cells that destroy bacteria, viruses, and infections entering your body, especially during cold and flu...

SUZHOU, China, Nov. 3, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced today that the company has enrolled and dosed its first patient with advanced or refractory solid tumors in a clinical trial of ALK-1 antibody (GT90001) in combination with KN046 on November 2 in Taiwan, China. This study...

FRISCO, Texas, Nov. 2, 2021 /PRNewswire/ -- Argon Medical Devices, Inc., a global manufacturer of specialty devices for Interventional Radiology, Vascular Surgery, and Interventional Cardiology, formally announced the launch of two unique portal vein access sets intended for transjugular liver access in diagnostic and interventional procedures.  The SCORPION® Portal Vein Access Series addresses the common challenges physicians encounter...